Automated microinjection for zebrafish xenograft models

Yi Ding,Kees-Jan van der Kolk,Wietske van der Ent,Michele Scotto di Mase,Saskia Kowald,Jenny Huizing,Jana M Vidal Teuton,Gunja Mishra,Maxime Kempers,Rusul Almter,Sandra Kunz,Laurine Munier,Carl Koschmann,Sebastian M. Waszak,Vincenzo Di Donato,Sylvia Dyballa,Peter Ten Dijke,Camila Vicencio Esguerra,Lasse D. Jensen,Jan de Sonneville

DOI: https://doi.org/10.1101/2024.08.13.607596

2024-09-04

Abstract:Zebrafish xenograft models have been increasingly recognized for their ability to predict patient responses to cancer therapeutics, suggesting their potential as diagnostic tools in clinical settings. However, these models require the precise microinjection of cancer cell suspensions in many small and fragile zebrafish larvae. Manual injections are so challenging that, even after months of training, variability in experimental results persists among researchers. This limits the uptake and deployment of zebrafish xenograft models for clinical use and drug discovery. To address this challenge, we have designed, built, and validated an automated microinjection robot. Combined results of injections into the vasculature, perivitelline space, and hindbrain ventricle demonstrated an average injection success rate of approximately 60%, with a larvae survival rate exceeding 70%, comparable to manual injections using a traditional micromanipulator. Notably, the full automated mode was twice as fast as manual injections. This automation of the microinjection process significantly reduces the need for extensive personnel training while it enhances reproducibility, efficiency, and accuracy, paving the way for more extensive use of zebrafish xenograft models in drug discovery and patient diagnostics.

Cancer Biology

What problem does this paper attempt to address?

The paper aims to address the challenging issue of microinjection techniques in the zebrafish xenotransplantation model. Specifically:

- **Challenges of Microinjection Techniques**: Manually performing microinjections on zebrafish larvae is very difficult. Even after months of training, there are still significant differences in experimental results among researchers. This limits the widespread use of the zebrafish xenotransplantation model in clinical applications and drug discovery.

To solve the above problems, the research team designed, manufactured, and validated an automated microinjection robot. This robot can significantly reduce the training requirements for operators, improve the reproducibility, efficiency, and accuracy of experiments, thereby promoting the broader application of the zebrafish xenotransplantation model in drug discovery and patient diagnosis. Experimental results show that when injecting into three sites: the vasculature, the yolk sac periphery, and the posterior brain ventricle, the average injection success rate is about 60%, and the larval survival rate exceeds 70%, which is comparable to traditional manual injection. Additionally, the injection speed in fully automated mode is twice that of manual injection.